Neuroblastoma of the urinary bladder in an infant clinically detected by hematuria
Carmen Sáez MD
Department of Pathology, Hospital Universitario Virgen del Rocío, Seville, Spain
Search for more papers by this authorCatalina Márquez MD
Unit of Pediatric Oncology, Department of Pediatrics, Hospital Universitario Infantil Virgen del Rocío, Seville, Spain
Search for more papers by this authorEduardo Quiroga MD
Unit of Pediatric Oncology, Department of Pediatrics, Hospital Universitario Infantil Virgen del Rocío, Seville, Spain
Search for more papers by this authorFelipe Borderas MD
Department of Pathology, Hospital Universitario Virgen del Rocío, Seville, Spain
Search for more papers by this authorJosé Alfaro MD
Unit of Pediatric Oncology, Department of Pediatrics, Hospital Universitario Infantil Virgen del Rocío, Seville, Spain
Search for more papers by this authorGregorio Pineda MD
Unit of Pediatric Oncology, Department of Pediatrics, Hospital Universitario Infantil Virgen del Rocío, Seville, Spain
Search for more papers by this authorJuan M. Loizaga MD
Department of Pathology, Hospital Universitario Virgen del Rocío, Seville, Spain
Search for more papers by this authorCorresponding Author
Ana M. Alvarez MD
Department of Pathology, Hospital Universitario Virgen del Rocío, Seville, Spain
Unidad de Oncología Pediátrica, Hospital Universitario Infantil Virgen del Rocío, Avenida Manuel Siurot s/n, Seville 41013, SpainSearch for more papers by this authorCarmen Sáez MD
Department of Pathology, Hospital Universitario Virgen del Rocío, Seville, Spain
Search for more papers by this authorCatalina Márquez MD
Unit of Pediatric Oncology, Department of Pediatrics, Hospital Universitario Infantil Virgen del Rocío, Seville, Spain
Search for more papers by this authorEduardo Quiroga MD
Unit of Pediatric Oncology, Department of Pediatrics, Hospital Universitario Infantil Virgen del Rocío, Seville, Spain
Search for more papers by this authorFelipe Borderas MD
Department of Pathology, Hospital Universitario Virgen del Rocío, Seville, Spain
Search for more papers by this authorJosé Alfaro MD
Unit of Pediatric Oncology, Department of Pediatrics, Hospital Universitario Infantil Virgen del Rocío, Seville, Spain
Search for more papers by this authorGregorio Pineda MD
Unit of Pediatric Oncology, Department of Pediatrics, Hospital Universitario Infantil Virgen del Rocío, Seville, Spain
Search for more papers by this authorJuan M. Loizaga MD
Department of Pathology, Hospital Universitario Virgen del Rocío, Seville, Spain
Search for more papers by this authorCorresponding Author
Ana M. Alvarez MD
Department of Pathology, Hospital Universitario Virgen del Rocío, Seville, Spain
Unidad de Oncología Pediátrica, Hospital Universitario Infantil Virgen del Rocío, Avenida Manuel Siurot s/n, Seville 41013, SpainSearch for more papers by this author35:5<488::aid-mpo8>3.0.co;2-e.fp.png)
REFERENCES
- 1Shimada H, Chatten J, Newton WA Jr, et al. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 1984; 73: 405–416.
- 2Kelly DR, Joshi VV. Neuroblastoma and related tumors. In: DM Parham, editor. Pediatric neoplasia: morphology and biology. Philadelphia: Lippincott-Raven; 1996. p 105–152.
- 3Knoedler CJ, Kay R, Knoedler JP Sr, Wiig TH. Pelvic neuroblastoma. J Urol 1989; 141: 905–907.
- 4Ijiri R, Tanaka Y, Kou K, et al. Bladder origin neuroblastoma detected by mass screening. Urology 1998; 52: 1139–1141.
- 5Yokoyama S, Hirakawa H, Ueno S, et al. Neuroblastoma of the urinary bladder, preclinically detected by mass screening. Pediatrics 1999; 103: e67.
- 6Nitschke R, Smith EI, Shochat S, et al. Localized neuroblastoma treated by surgery: a Pediatric Oncology Group Study. J Clin Oncol 1998; 6: 1271–1279.
- 7Brodeur GM. Molecular pathology in human neuroblastoma. Semin Diagn Pathol 1994; 11: 118–125.
- 8Joshi VV, Cantor AB, Altshuler G, et al. Recommendations for modification of terminology of neuroblastic tumors and prognostic significance of Shimada classification: a clinicopathological study of 213 cases from the Pediatric Oncology Group. Cancer 1992; 69: 2183–2196.
10.1002/1097-0142(19920415)69:8<2183::AID-CNCR2820690828>3.0.CO;2-C CAS PubMed Web of Science® Google Scholar
- 9Cohn SL, Look AT, Joshi VV, et al. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group Study. Cancer Res 1995; 55: 721–726.
- 10Hartwig NG, Caron HN, den Hollander JC, et al. Neuroblastoma 4S with an unfavorable biological marker: what to do? Med Pediatr Oncol 1999; 32: 294–301.
10.1002/(SICI)1096-911X(199904)32:4<294::AID-MPO11>3.0.CO;2-2 CAS PubMed Web of Science® Google Scholar
- 11Kushner BH, Cheung N-K V, La Quaglia M, et al. Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy. J Clin Oncol 1996; 14: 373–381.
- 12Evans AE, Silber J, Shpilsky A, D'Angio GJ. Successful management of low-stage neuroblastoma without adjuvant therapies. J Clin Oncol 1996; 14: 2504–2510.
- 13Perez CA, Matthay KK, Atkinson JB, et al. Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a Children's Cancer Group Study. J Clin Oncol 2000; 18: 18–26.
